MedPath

MebendamaX

Mebendamax Pinworm (AS)

Approved
Approval ID

1d75b912-3550-7d4c-e063-6294a90ad5fa

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 18, 2025

Manufacturers
FDA

Pharmadel LLC

DUNS: 030129680

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pyrantel Pamoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55758-441
Application NumberM024
Product Classification
M
Marketing Category
C200263
G
Generic Name
Pyrantel Pamoate
Product Specifications
Route of AdministrationORAL
Effective DateJune 18, 2025
FDA Product Classification

INGREDIENTS (11)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
PYRANTEL PAMOATEActive
Quantity: 180 mg in 1 1
Code: 81BK194Z5M
Classification: ACTIM
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 3/5/2024

Principal Display Panel

PDP mebendamax

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 3/5/2024

Use

For the treatment of pinworms.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 3/4/2024

Directions

READ THE PACKAGE CAREFULLY BEFORE TAKING THIS MEDICATION.

  • take only according to directions
  • do not exceed the recommended dosage, unless directed by a doctor
  • medication should only be taken one time as a single dose; do not repeat treatment
  • when one individual in a household has pinworms, the entire household should be treated unless otherwise advised *adults, children 12 years of age and over, and children 2 years to under 12 years of age:
  • this product can be taken any time of day, with or without meals. It may be taken alone or with milk or fruit juice.
  • use of a laxative is not necessary before, during, or after medication
  • oral dosage is a single dose of 5 mg of pyrantel base per pound or 11 mg of pyrantel base per kilogram of body weight not to exceed 1 gram (1000mg) *children under 25 lbs. or 2yrs old: do not use unless directed by a doctor

Weight

Dosage(taken as a single (1) dose as per weight)

Less than 25 lb. or under 2 yrs. old

do not use unless directed by a doctor

25-37 lbs.

2 tablets (125 mg)

38-62 lbs.

4 tablets (250 mg)

63-87 lbs.

6 tablets (375 mg)

88-112 lbs.

8 tablets (500 mg)

113-137 lbs.

10 tablets (625 mg)

138-162 lbs.

12 tablets (750 mg)

163-187 lbs.

14 tablets (875 mg)

188 lbs. and over

16 tablets (1,000 mg)

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 3/5/2024

Inactive ingredients

croscarmellose sodium, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, potassium sorbate, povidone k-30, silicon dioxide, talc

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 3/5/2024

Dist. by:

Pharmadel LLC.

New Castle, DE 19720

1-866-359-3478

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 3/5/2024

Active ingredient & Purpose

Active ingredient (in each tablet)

Purpose

Pyrantel pamoate 180 (equivalent to 62.5mg of pyrantel base).........

Pinworm treatment

WARNINGS SECTION

LOINC: 34071-1Updated: 3/5/2024

Warnings

Ask a doctor before use if you

  • have liver disease
  • are pregnant

Stop use and ask a doctor if

  • any symptoms or pinworms are still present after treatment
  • any worms other than pinworms are present before or after treatment
  • any of these symptoms that sometimes occur after taking the product persist:
  • abdominal cramps
  • nausea
  • vomiting
  • diarrhea
  • headache
  • dizziness

Keep out of reach of children.

In case of an accidental overdose get medical help or contact a Poison Control Center right away.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MebendamaX - FDA Drug Approval Details